Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.61 is 57% below its 5-year average of 6.14, near the low end of its 5-year range (2.61–12.89).
As of the fiscal period ended Tuesday, June 30, 2026. 20.28% below its 12-month average of 3.28.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.61.
CURRENT RATIO
2.61
CURRENT RATIO AVG TTM
3.28
CURRENT RATIO AVG 3Y
4.24
CURRENT RATIO AVG 5Y
6.14
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.28%
CURRENT VS 3Y AVG
-38.37%
CURRENT VS 5Y AVG
-57.44%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 638 covered companies
CURRENT VS SECTOR MEDIAN
-23.01%
vs the sector median at left
Bolt Biotherapeutics, Inc.
Market Cap
$6.92M
Current Ratio
2.61
TTM Avg
3.28
3Y Avg
4.24
5Y Avg
6.14
Market Cap
$6.67M
Current Ratio
10.21
TTM Avg
3.61
3Y Avg
3.34
5Y Avg
4.20
Market Cap
$7.20M
Current Ratio
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.25M
Current Ratio
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | $6.92M | 2.61 | 3.28 | 4.24 | 6.14 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | 1.81 | 4.14 | 10.76 | 11.50 |
| Aclarion, Inc. (ACON)vs › | $6.70M | 16.20 | 7.76 | 4.60 | 3.08 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.67M | 10.21 | 3.61 | 3.34 | 4.20 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.20M | 45.95 | 58.73 | 40.89 | 40.89 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.20M | 0.18 | 0.90 | 2.08 | 1.78 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.25M | 0.31 | 1.26 | 1.91 | 5.47 |
| KALA BIO, Inc. (KALA)vs › | $7.27M | 6.88 | 3.46 | 4.15 | 4.60 |
| Longeveron Inc. (LGVN)vs › | $7.32M | 2.63 | 4.46 | 3.65 | 4.69 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.33M | 1.37 | 4.18 | 4.61 | 4.18 |
Current Ratio
2.61
Quick Ratio
2.61
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.61 |
| 2026-03-31 | 3.51 |
| 2025-12-31 | 3.59 |
| 2025-09-30 | 3.57 |
| 2025-06-30 | 3.11 |
| 2025-03-31 | 3.13 |
| 2024-12-31 | 3.20 |
| 2024-09-30 | 3.16 |
| 2024-06-30 | 4.28 |
| 2024-03-31 | 5.68 |
| 2023-12-31 | 5.17 |
| 2023-09-30 | 6.69 |
| 2023-06-30 | 7.42 |
| 2023-03-31 | 8.10 |
| 2022-12-31 | 7.47 |
| 2022-09-30 | 7.23 |
| 2022-06-30 | 9.73 |
| 2022-03-31 | 10.16 |
| 2021-12-31 | 8.87 |
| 2021-09-30 | 9.39 |
| 2021-06-30 | 12.89 |
| 2021-03-31 | 22.58 |
| 2020-12-31 | 2.25 |
| 2020-09-30 | 4.01 |
| 2020-06-30 | 6.87 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 4.15 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
